Jilin Aodong Pharmaceutical Group Co., Ltd.
000623
Rangering i aksjer
#4951
Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally... Jilin Aodong Pharmaceutical Group Co., Ltd. operates in China, principally focusing on the production and distribution of a broad spectrum of pharmaceutical goods. Its product line encompasses various drug forms like oral liquids, injections, capsules, granules, pills, and tablets, as well as traditional Chinese herbal medicines, powders, syrups, and spirits. The company also produces specialized medicinal products, including enzymes, biochemical drugs, and plant-based chemical medicines. In addition to its core pharmaceutical activities, Jilin Aodong diversifies its operations across several other sectors. These include highway construction and toll management, animal husbandry, the creation of specialty chemicals, and the provision of heat and water. The company further engages in the wholesale, retail, and distribution of medicines, packaging design and printing, the manufacturing of medicinal packaging materials, and delivers information consulting and advertising design solutions. Founded in 1957, its corporate headquarters are situated in Dunhua, China.
Aksjekurs
$2.47
Markedsverdi
$2.95B
Endring (1 dag)
-1.22%
Endring (1 år)
-14.21%
Land
CN
Handel Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
Kategori
Healthcare
EPS for Jilin Aodong Pharmaceutical Group Co., Ltd. (000623)
EPS per June 2026 TTM: $0.41
Ifølge de siste økonomiske rapportene og aksjekursen til Jilin Aodong Pharmaceutical Group Co., Ltd. er selskapets nåværende EPS (TTM) $0.41. Ved slutten av 2023 hadde selskapet en EPS på $0.18, en nedgang sammenlignet med EPS-en i 2022 som var $0.23.
EPS-historikk for Jilin Aodong Pharmaceutical Group Co., Ltd. fra 2000 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2026 (TTM) | $0.41 | 126.22% |
| 2024 | $0.18 | -1.58% |
| 2023 | $0.18 | -19.29% |
| 2022 | $0.23 | -7.25% |
| 2021 | $0.25 | 8.30% |
| 2020 | $0.23 | 30.38% |
| 2019 | $0.17 | 48.67% |
| 2018 | $0.12 | -52.46% |
| 2017 | $0.25 | 17.77% |
| 2016 | $0.21 | -39.20% |
| 2015 | $0.34 | 74.31% |
| 2014 | $0.20 | 31.33% |
| 2013 | $0.15 | 68.92% |
| 2012 | $0.09 | -67.27% |
| 2011 | $0.27 | 67.37% |
| 2010 | $0.16 | -5.43% |
| 2009 | $0.17 | 58.12% |
| 2008 | $0.11 | -53.71% |
| 2007 | $0.23 | 336.13% |
| 2006 | $0.05 | 355.08% |
| 2005 | $0.01 | 19.19% |
| 2004 | $0.01 | 17.86% |
| 2003 | $0.01 | 31.25% |
| 2002 | $0.01 | 128.57% |
| 2001 | 0.00 | -59.42% |
| 2000 | $0.01 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 36.62% |
IN
|
